1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
61E593F0F6F880147852571C000533067
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/brand-equity-and-loyalty-through-oncology-marketing?opendocument
18
19opendocument
2018.212.90.230
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




Products & Services

Brand Equity and Loyalty Through Oncology Marketing

Brand Equity and Loyalty Through Oncology Marketing

ID: PSM-218


Features:

2 Info Graphics

54 Metrics

17 Narratives

2 Best Practices


Pages: 82


Published: Pre-2014


Delivery Format: Shipped


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
With easy access to information on the Internet, more people than ever are taking the responsibility of researching their own disease treatment options -- especially with such life-threatening illnesses as cancer. The Internet is a valuable tool that pharmaceutical companies can use to help market their oncology drugs, inform their customers and retain their customer loyalty. This informative 82-slide presentation looks at the global trends and best practices in effectively using web sites to market oncology products to patients, oncologists and key opinion leaders. The findings in this document help pharmaceutical or biotech companies address how these companies successfully use web sites to market their products.

Key topics included in this research include:
--Types of information and services offered to patients, oncologists and key opinion leaders
--Perception of value among key audiences
--Barriers to online activities
--Measurement of activities

An example of one key high-level finding is as follows:
* Employ oncology web sites as a platform to better serve oncologists and patients by providing clinical trial resources that both inform and help recruit potential investigators and patients.

This research was conducted on behalf of a Business Excellence Board (BEB) member. Nine executives from eight pharmaceutical and biotech companies participated in this research. Additional research was conducted by examining and analyzing the web sites of top-selling oncology products such as Gleevec, Procrit, Taxol and many others.

Industries Profiled:
Pharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Health Care; Chemical


Companies Profiled:
Bayer; CTI Molecular Imaging; Myriad; Abbott; Schering-Plough; Genentech; Roche